Nature Announces Reproducibility Initiative

The journal is sharpening its review of life science papers and giving authors additional space to document more detailed methods.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NATIONAL CANCER INSTITUTE, DIANE A. REIDThe prestigious journal Nature is making an effort to publish fewer irreproducible papers, it announced in an editorial yesterday (April 24). The journal will get rid of space limitations on Methods sections and will commission statisticians to help review some papers, among other measures.

The announcement follows widespread discussion of how to solve the problem of irreproducibility. “The problems arise in laboratories, but journals such as this one compound them when they fail to exert sufficient scrutiny over the results that they publish, and when they do not publish enough information for other researchers to assess results properly,” the Nature editors wrote.

The journal is encouraging scientists to be more transparent about their data, statistics, and methods, including posting raw data online. A checklist for authors submitting life science papers specifies necessary information about sample sizes, statistical tests, and blinding, among other topics. It also asks researchers to disclose sources and profiles of biologically variable substances, such as cell lines and antibodies.

Additionally, the editorial places blame for irreproducibility ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo